St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Destiny Hinton
Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.
Stories by Destiny Hinton
Exploring the interplay between vaccines and immune system development in infants
Explore new research delving into pediatric immune responses to vaccination
St. Jude Global builds pathology and laboratory medicine capacity and community
The St. Jude Global Pathology and Laboratory Medicine Transversal aims to improve diagnostic testing worldwide.
Shared Resource Spotlight: St. Jude Vector Laboratory (SJVL)
The St. Jude Vector Laboratory advances gene therapy through viral vectors, advancing scientific and therapeutic innovation.
Bridging the pediatric cancer budgeting gap in national cancer control plans
A new rapid budgeting tool increases the likelihood pediatric cancer will be included in national cancer control plans globally.
5 Questions for Laura Jolovic
Meet St. Jude radiation therapist Laura Jolovic and learn how she provides care for children with cancer as well as mentors students interested in a career in pediatric radiation oncology.
CRISPR kickstarts combination drug discovery for neuroblastoma
A CRISPR screen reveals a potential combination therapy for relapsed neuroblastoma.
Building blocks: St. Jude Global guides reestablishment of health care capacity during crisis
St. Jude Global helps provide a framework for rebuilding health care capacity after a crisis.
Finding the big-TIME players holding back CAR T–cell therapy for high-grade gliomas
Explore how tumor-associated macrophages shape CAR T-cell therapy efficacy in high-grade gliomas.
5 Questions for Alaa Refaat
Meet St. Jude senior scientist Alaa Refaat, PhD, and learn about his work to develop treatments for childhood brain tumors using chemical biology approaches.
Ribosome production presents a new therapeutic opportunity against Wilms tumor
Discover how disruption ribosomes creation provides promise for “undruggable” cancers.